Selective Activation of a Chimeric Gi1/GsG Protein α Subunit by the Human IP Prostanoid Receptor: Analysis Using Agonist Stimulation of High Affinity GTPase Activity and [35S]Guanosine-5′-O-(3-thio)triphosphate Binding

Abstract

A FLAG-tagged form of the human IP prostanoid receptor was expressed stably in HEK 293 cells. This bound [3H]iloprost with high affinity and stimulated cAMP production when exposed to agonist. Iloprost produced weak stimulation of GTPase activity and [35S]guanosine-5′-O-(3-thio)triphosphate binding in membranes of these cells. Pretreatment of cells with pertussis toxin did not modify iloprost-mediated stimulation, but this was blocked by cholera toxin. The effects of iloprost were not increased by coexpression of either G or Gi1α. In contrast, coexpression of a chimeric G protein α subunit in which the carboxyl-terminal six amino acids of Gi1α were altered to those of G resulted in robust stimulation by iloprost. Because the chimeric G protein α subunit (Gi1/Gs6α) is not a substrate for either pertussis or cholera toxin, pretreatment of cells coexpressing the IP prostanoid receptor and Gi1/Gs6α with a mixture of these toxins resulted in resolution of the signal derived from activation of the chimeric G protein. Agonist-stimulated [35S]guanosine-5′-O-(3-thio)triphosphate binding and GTPase activity assays are the most commonly used strategies to examine interactions between G protein-coupled receptors and G proteins. These usually are not appropriate for receptors such as the IP prostanoid receptor that interact with G proteins with low rates of guanine nucleotide exchange and hydrolysis. Chimeric G proteins such as Gi1/Gs6α that allow appropriate receptor contacts to be converted to the higher nucleotide turnover rates typical of the Gi family G proteins can overcome this and offer a novel means to examine agonist function at such receptors.

Footnotes

  • Send reprint requests to: Dr. Graeme Milligan, Davidson Building, University of Glasgow, University Avenue, Glasgow G12 8QQ, Scotland. E-mail: g.milligan{at}bio.gla.ac.uk

  • This work was supported by the Medical Research Council and the Biotechnology and Biosciences Research Council (UK). C.W.F. received a studentship from the National Science and Technology Board of Singapore. D.S.B. received a CASE studentship from the Biotechnology and Biosciences Research Council.

  • Abbreviations:
    FhIPR
    FLAG-tagged human IP prostanoid receptor
    hIPR
    human IP prostanoid receptor
    SDS
    sodium dodecyl sulfate
    PAGE
    polyacrylamide gel electrophoresis
    PCR
    polymerase chain reaction
    HEPES
    4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
    HEK
    human embryonic kidney
    GTPγS
    guanosine-5′-O-(3-thio)triphosphate
    PBS
    phosphate-buffered saline
    GPCR
    G protein-coupled receptor
    DOTAP
    N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium methylsulfate
    • Received February 24, 1998.
    • Accepted April 14, 1998.
« Previous | Next Article »Table of Contents